India is launching a major initiative to boost its biopharmaceutical manufacturing and aims to reduce reliance on China for crucial drug components. It also seeks to capitalize on upcoming patent expirations of major global drugs. India will focus on becoming a hub for biosimilars and emerging biologics.Read More
